≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Endocrine disorders, other/unspecified

DOID EFO Endpoint Browser PheWeb

E4_ENDODISNAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E34.8, E34.9
  • Hospital discharge: ICD-9 — 2592
  • Hospital discharge: ICD-8 — 2589
  • Cause of death: ICD-10 — E34.8, E34.9
  • Cause of death: ICD-9 — 2592
  • Cause of death: ICD-8 — 2589

2 out of 7 registries used, show all original rules.

748

4. Check minimum number of events

None

748

5. Include endpoints

None

748

6. Filter based on genotype QC (FinnGen only)

724

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4629 2915 1690
Only index persons 4059 2629 1430
Unadjusted period prevalence (%)
Whole population 0.07 0.08 0.05
Only index persons 0.08 0.10 0.05
Median age at first event (years)
Whole population 45.31 43.58 47.96
Only index persons 42.47 41.28 44.67

-FinnGen-

Key figures

All Female Male
Number of individuals 724 485 239
Unadjusted period prevalence (%) 0.15 0.17 0.11
Median age at first event (years) 43.99 40.67 50.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
748
Matched controls
7480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
307.7
591
*
H02AB09
ATC
hydrocortisone; systemic
26.7
138.7
98
42
ZXE00
NOMESCO Finland
One hour or less
4.1
78.6
457
2069
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
8.5
68.6
94
124
H03AA01
ATC
levothyroxine sodium; systemic
3.7
65.2
305
1162
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
149.3
65.1
68
5
25898
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti
+∞
62.4
59
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.2
62.2
117
217
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
88.9
59.0
65
8
SPAT1262
SPAT
Handing over of treatment supplies
4.0
58.6
217
699
XX3DW
NOMESCO Finland
Time consuming IT work
4.3
53.8
162
447
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
53.3
379
1820
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.7
52.0
106
211
25899
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system
+∞
51.7
49
*
WX723
NOMESCO Finland
CPAP therapy
6.9
50.6
83
133
SPAT1312
SPAT
General health counselling
3.0
47.9
340
1607
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.9
46.4
162
494
E34.8
ICD-10 Finland
Other specified endocrine disorders
+∞
46.3
44
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
44.2
42
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
+∞
42.1
40
*
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
15.5
41.9
37
25
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.9
41.7
79
146
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.7
41.3
104
247
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.8
41.0
388
2093
SPAT1377
SPAT
Polysomnography
6.9
40.3
65
102
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.0
39.2
244
1052
NH3EA
NOMESCO Finland
Feet X-ray examination with load
8.5
38.4
51
64
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
37.8
406
2304
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.4
37.7
164
573
WX780
NOMESCO Finland
Remote monitoring CPAP
5.5
36.8
75
148
SPAT1249
SPAT
Treatment-related counselling outside office
2.6
36.4
377
2092
SPAT1263
SPAT
Sampling
2.6
34.8
389
2224
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
34.6
33
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.7
34.4
283
1396
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
13.3
33.3
32
25
A11CC03
ATC
alfacalcidol; systemic
9.3
32.7
40
45
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
32.4
140
484
XFE00
NOMESCO Finland
Epicardial ultrasonography
9.7
31.1
37
40
ZXD00
NOMESCO Finland
Emergency procedure
6.2
30.8
54
92
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
29.3
127
438
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
29.3
266
1356
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
29.2
247
1217
XX2RW, ,
NOMESCO Finland
11.1
27.9
30
28
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.1
27.9
50
87
G02CB01
ATC
bromocriptine; systemic
8.1
27.9
38
49
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
27.2
26
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.3
26.5
323
1857
HAHOM, ,
NOMESCO Finland
10.7
26.4
29
28
J01MA12
ATC
levofloxacin; systemic
2.7
26.1
172
746
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
26.0
107
357
H01CB02
ATC
octreotide; parenteral
96.9
25.8
28
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
139.9
25.8
27
*
UJF32
NOMESCO Finland
Coloscopy
2.4
25.4
234
1188
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.9
25.2
35
46
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
25.1
24
*
104
Kela drug reimbursment
Thyroid insufficiency
3.6
24.9
88
266
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
258.3
24.8
25
*
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
9.7
24.5
29
31
SPAT1310
SPAT
Counselling related to known health issue
2.3
24.3
287
1614
106
Kela drug reimbursment
Hypoparathyroidism
+∞
24.1
23
*
Z01.9
ICD-10 Finland
Special examination, unspecified
3.8
24.0
79
227
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.4
23.6
48
94
OAB50, ,
SPAT
4.0
23.2
70
189
WX402
NOMESCO Finland
General anaesthesia
2.4
23.0
196
956
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
22.9
281
1599
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
22.7
217
1111
A02BC01
ATC
omeprazole; systemic
2.3
22.7
244
1313
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
4.5
22.7
57
134
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.8
22.5
42
76
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
22.1
70
196
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
22.0
21
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
21.9
103
371
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
82.6
21.8
24
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.3
21.6
45
90
SPAT1281
SPAT
Other administrative function
3.3
21.5
90
302
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
8.5
21.5
28
34
121
Kela drug reimbursment
Severe hypofunction of sexual glands
7.0
21.4
33
49
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.0
21.0
101
368
WVA30, ,
SPAT
4.0
20.9
63
170
SPAT1301
SPAT
No procedures
2.1
20.6
266
1532
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
20.3
103
386
-44
ICPC
Preventive immunization/medic
3.2
20.1
86
292
H01AC01
ATC
somatropin; parenteral
+∞
19.9
19
*
SPAT1153
SPAT
Removal of sutures
2.1
19.9
265
1540
UDC00
NOMESCO Finland
Ear microscopy
3.3
19.8
81
268
G47.3
ICD-10 Finland
Sleep apnoea
2.3
19.7
196
1014
JN4AD
NOMESCO Finland
Body CT examination
3.0
19.5
95
348
SPAT1260
SPAT
Consultation of another employee
2.4
19.3
161
771
N06AA09
ATC
amitriptyline; systemic
2.9
19.3
100
379
H01CB03
ATC
lanreotide; parenteral
194.7
18.6
19
*
-1, ,
SPAT
4.0
18.1
53
140
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
17.8
55
151
E21.0
ICD-10 Finland
Primary hyperparathyroidism
97.4
17.6
19
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
17.4
124
551
AA1AD
NOMESCO Finland
CT of head and brain
2.1
17.4
211
1173
A12AA04
ATC
calcium carbonate; oral
14.3
17.4
29
21
C03CA01
ATC
furosemide; systemic
2.1
16.9
205
1138
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
16.9
306
1959
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
13.1
16.8
29
23
205
Kela drug reimbursment
Chronic hypertension
2.1
16.6
188
1016
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
41.1
16.4
20
5
S02.51
ICD-10 Finland
Fracture of tooth, open
2.6
16.3
101
419
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
16.3
558
4397
A02BC02
ATC
pantoprazole; systemic
2.0
16.2
518
3979
R5140
NOMESCO Finland
Monitoring the use of the aid
2.6
16.2
103
433
E0000UV, ,
ATC
1.9
16.2
337
2252
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
16.1
163
842
WX400
NOMESCO Finland
Inhalation anesthesy
3.6
16.1
54
157
H02AB06
ATC
prednisolone; systemic
1.9
16.0
371
2562
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
4.4
15.9
40
94
SPAT1211
SPAT
Application of soft bandage
2.8
15.9
84
321
-50
ICPC
Medication/prescr/renewal
3.9
15.8
48
130
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
61.4
15.8
18
*
XF404
NOMESCO Finland
Ambulatory ECG
2.8
15.7
83
317
-54
ICPC
Repair/fix-suture/cast/prosth device
5.8
15.7
29
52
E26.0
ICD-10 Finland
Primary hyperaldosteronism
86.9
15.6
17
*
C10AC01
ATC
colestyramine; oral
4.8
15.5
35
75
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
163.3
15.5
16
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
15.5
243
1472
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
15.3
87
345
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
15.3
90
364
SPAT1238
SPAT
Brief therapy
5.4
15.2
30
57
R06.0
ICD-10 Finland
Dyspnoea
2.0
15.2
212
1232
R01AD12
ATC
fluticasone furoate; nasal
1.9
15.2
272
1721
N06AX21
ATC
duloxetine; oral
2.4
15.2
115
524
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
15.0
84
331
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.9
14.9
44
117
SCA02
NOMESCO Finland
Preventive oral health care
2.5
14.4
96
412
B03BA03
ATC
hydroxocobalamin; parenteral
3.5
14.3
51
154
N06AX16
ATC
venlafaxine; oral
2.2
14.3
135
676
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
14.1
133
665
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
6.0
14.1
25
43
J01FF01
ATC
clindamycin; systemic
1.9
13.9
218
1315
T90
ICPC
Diabetes non-insulin dependent
2.0
13.8
175
979
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
13.7
354
2489
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
13.6
49
149
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
13.6
13
*
E83.50
ICD-10 Finland
Hypercalcemia
16.6
13.5
21
13
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
142.5
13.5
14
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
142.5
13.5
14
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
3.3
13.4
52
166
N02AX02
ATC
tramadol; systemic, rectal
1.8
13.4
323
2222
JN4CD
NOMESCO Finland
Very extensive body CT
4.1
13.3
37
94
N04BC06
ATC
cabergoline; oral
40.9
13.2
16
*
UKC02
NOMESCO Finland
Cystoscopy
2.3
13.1
112
537
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
5.7
13.0
24
43
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
12.9
87
375
OAB72
NOMESCO Finland
Weight control and weight loss guidance
11.8
12.9
23
20
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
12.8
66
249
N05BA04
ATC
oxazepam; oral
1.9
12.6
212
1301
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.4
12.6
32
76
2592A
ICD-9 Finland
Other endocrine disorders, Carcinoid syndrome
+∞
12.5
12
*
A12AA06
ATC
calcium lactate gluconate; oral
+∞
12.5
12
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
12.5
12
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
12.5
12
*
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
12.5
12
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
12.5
89
393
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
132.1
12.5
13
*
R55
ICD-10 Finland
Syncope and collapse
2.4
12.4
87
382
KH1AD
NOMESCO Finland
CT of urinary organs
4.0
12.4
35
90
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
3.4
12.4
45
138
H03BB01
ATC
carbimazole; oral
3.3
12.3
47
149
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
12.2
153
849
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
5.6
12.2
23
42
YHMAS, ,
NOMESCO Finland
12.7
12.2
21
17
ZXD05
NOMESCO Finland
Urgent procedure
1.8
12.1
241
1555
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.4
12.0
30
70
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
5.8
12.0
22
39
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
12.0
11.9
21
18
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
11.9
208
1290
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.6
11.8
40
117
T99
ICPC
Endocr/metab/nutrit disease other
5.2
11.8
24
47
A02BA02
ATC
ranitidine; systemic
2.0
11.8
149
829
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.5
11.8
29
67
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
11.7
67
266
SAA04
NOMESCO Finland
Special examination of mouth
3.0
11.7
54
191
Z31.5
ICD-10 Finland
Genetic counselling
2.8
11.7
59
220
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
11.7
185
1111
321
Kela drug reimbursment
Paricalcitol and cinacalcet
66.0
11.6
13
*
T82
ICPC
Obesity
3.3
11.6
45
144
C07AB02
ATC
metoprolol; systemic
2.0
11.5
142
782
WZA10
NOMESCO Finland
Extensive medical or dental certificate
5.8
11.5
21
37
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
121.8
11.5
12
*
H02AA02
ATC
fludrocortisone; oral
15.3
11.3
18
12
C03DA01
ATC
spironolactone; oral
2.3
11.2
89
412
E03
ICD-10 Finland
Other hypothyroidism
2.7
11.2
61
236
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
11.2
66
266
K02
ICD-10 Finland
Dental caries
2.6
11.2
66
266
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
11.2
102
501
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
11.2
61
237
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.1
317
2256
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
4.6
11.0
26
58
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
11.0
114
589
R50.9
ICD-10 Finland
Fever, unspecified
2.1
11.0
123
654
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
10.9
68
282
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
10.8
109
557
R53
ICD-10 Finland
Malaise and fatigue
1.8
10.8
187
1151
SPAT1097
SPAT
Recording of ECG
2.1
10.8
113
586
Z56.5
ICD-10 Finland
Uncongenial work
28.5
10.8
14
5
SPAT1254
SPAT
Administration of medicine
2.1
10.7
107
544
N06AB04
ATC
citalopram; systemic
1.9
10.7
168
1002
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
21.8
10.7
15
7
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
10.6
92
442
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
11.4
10.6
19
17
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
5.1
10.6
22
44
A02BC05
ATC
esomeprazole; systemic
1.7
10.6
308
2196
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.5
10.5
37
111
J01DB01
ATC
cefalexin; oral
1.9
10.5
619
5335
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
111.5
10.4
11
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
111.5
10.4
11
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
10.4
10
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
10.4
64
264
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
10.4
168
1011
SPAT1240
SPAT
Therapeutic discussion
2.2
10.3
94
462
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.6
10.3
34
98
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
10.2
186
1160
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.3
10.1
85
403
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
10.1
73
324
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
10.1
177
1090
130
Kela drug reimbursment
Malignant tumour
2.5
10.1
67
286
XKD00
NOMESCO Finland
Uroflowmetry
2.2
10.1
91
444
Z2221
NOMESCO Finland
Medical doctor
0.4
10.1
69
1413
HMAK, ,
NOMESCO Finland
2.1
10.1
102
521
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.1
10.1
21
42
N02AA05
ATC
oxycodone; systemic
2.0
9.9
122
670
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
9.9
150
883
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
9.9
109
575
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
17.0
9.9
15
9
N03AE01
ATC
clonazepam; systemic
2.7
9.9
52
198
R51
ICD-10 Finland
Headache
2.7
9.9
53
204
D82
ICPC
Teeth/gum disease
1.7
9.9
285
2018
WX204
NOMESCO Finland
Axillary plexus blockaced
3.3
9.8
37
116
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
9.8
92
457
A04AA02
ATC
granisetron; systemic, transdermal
2.6
9.8
57
229
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.5
9.7
33
97
H05BX01
ATC
cinacalcet; oral
55.7
9.7
11
*
C03AA03
ATC
hydrochlorothiazide; oral
2.4
9.7
66
286
SPAT1324
SPAT
Screening procedure
0.3
9.6
32
903
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
9.6
397
3067
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.2
9.6
38
123
R68.8
ICD-10 Finland
Other specified general symptoms and signs
11.6
9.6
17
15
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
9.5
107
568
N02BE01
ATC
paracetamol; systemic, rectal
2.1
9.5
660
5861
R06AE07
ATC
cetirizine; oral
1.6
9.5
336
2497
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
9.5
145
855
JAH01
NOMESCO Finland
Laparoscopy
3.0
9.5
43
151
C07AB07
ATC
bisoprolol; oral
1.6
9.5
322
2370
N05AH04
ATC
quetiapine; oral
1.9
9.4
142
834
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
9.4
9
*
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
+∞
9.4
9
*
L04AX01
ATC
azathioprine; systemic
3.1
9.3
39
131
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
9.2
78
371
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
9.2
184
1175
B01AB10
ATC
tinzaparin; parenteral
2.2
9.2
82
399
SPAT1094
SPAT
Continuous Positive Airway Pressure
7.9
9.2
20
26
L01BA01
ATC
methotrexate; systemic
3.3
9.1
34
106
XLA10, ,
NOMESCO Finland
2.9
9.1
44
160
WZC30
NOMESCO Finland
Teaching
1.9
9.1
123
696
C08CA02
ATC
felodipine; oral
2.4
9.1
65
288
Y0099
ICD-8 Finland
Investigation of endocrine system and metabolism
15.8
9.1
14
9
N06AX11
ATC
mirtazapine; oral
1.7
9.0
254
1777
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.7
8.9
47
179
L04AA06
ATC
mycophenolic acid; systemic
5.0
8.9
19
39
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
8.9
96
503
B81
ICPC
Anaemia vit B12/folate deficiency
3.3
8.9
33
103
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.1
8.8
36
119
XX9TE
NOMESCO Finland
Compementary ultrasound examination
9.6
8.8
17
18
E29.1
ICD-10 Finland
Testicular hypofunction
9.6
8.8
17
18
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.7
8.8
209
1398
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
8.7
94
493
-56
ICPC
Dressing/pressure/compress/tamponade
7.1
8.6
20
29
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.7
8.6
47
183
D07AC13
ATC
mometasone; topical
1.7
8.6
214
1449
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.8
8.5
26
71
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.2
8.5
22
53
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
8.5
37
127
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
8.5
227
1564
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
8.5
158
988
318
Kela drug reimbursment
Teriparatide
91.1
8.4
9
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.8
8.4
25
67
JN6AD
NOMESCO Finland
CT of torso and neck
5.0
8.4
18
37
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
5.0
8.4
18
37
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.7
8.4
19
41
J45
ICD-10 Finland
Asthma
2.1
8.4
85
435
102
Kela drug reimbursment
Diabetes insipidus
+∞
8.3
8
*
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
+∞
8.3
8
*
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
+∞
8.3
8
*
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
+∞
8.3
8
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
8.7
8.3
17
20
ED1AA
NOMESCO Finland
Mandibular X-ray examination
10.9
8.3
15
14
GD2SN
NOMESCO Finland
Lung ventilation SPECT
14.7
8.2
13
9
ZXA10
NOMESCO Finland
Bilateral
1.8
8.2
136
821
N06AX12
ATC
bupropion; oral
2.3
8.2
62
282
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
4.6
8.2
19
42
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
8.2
76
376
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.9
8.1
38
136
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.9
8.1
19
28
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.3
8.1
65
303
WX610
NOMESCO Finland
Patient controlled analgesia
9.1
8.1
16
18
N03AX09
ATC
lamotrigine; oral
2.6
8.1
47
189
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
8.1
92
491
R4180
NOMESCO Finland
Podiatric therapy
6.4
8.1
20
32
C08CA01
ATC
amlodipine; oral
1.6
8.0
247
1757
F33
ICD-10 Finland
Recurrent depressive disorder
3.6
8.0
26
74
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.9
8.0
23
60
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.9
8.0
38
137
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
8.0
124
732
S02.5
ICD-10 Finland
Fracture of tooth
3.4
8.0
28
84
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.1
8.0
33
110
SPAT1104
SPAT
Monitoring of emergency patient
2.5
7.9
51
215
A06AD11
ATC
lactulose; oral
2.0
7.9
95
516
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.9
157
997
N18.8
ICD-10 Finland
Other chronic renal failure
4.7
7.9
18
39
L68.0
ICD-10 Finland
Hirsutism
13.2
7.9
13
10
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.1
7.8
21
52
N03AX16
ATC
[U] pregabalin
1.7
7.8
168
1090
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
7.8
300
2244
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
6.5
7.7
19
30
D07AC01
ATC
betamethasone; topical
1.6
7.7
256
1850
R01AD08
ATC
fluticasone; nasal
1.6
7.7
216
1499
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
15.2
7.7
12
8
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.6
7.7
46
187
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
7.5
7.7
17
23
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
7.5
7.7
17
23
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.9
7.7
36
129
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.7
7.7
41
158
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
7.6
148
934
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.1
7.5
31
103
ZXA00
NOMESCO Finland
Right side
0.5
7.5
66
1247
EBA10
NOMESCO Finland
Operative extraction of tooth
1.9
7.5
99
555
M79.6
ICD-10 Finland
Pain in limb
1.5
7.5
307
2324
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
7.5
255
1852
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
7.5
84
446
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
7.4
132
811
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.3
7.4
27
83
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
80.9
7.4
8
*
E21.2
ICD-10 Finland
Other hyperparathyroidism
80.9
7.4
8
*
H05AA02
ATC
teriparatide; parenteral
80.9
7.4
8
*
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
80.9
7.4
8
*
SPAT1325
SPAT
Vaccination
1.6
7.4
226
1599
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.8
7.4
16
21
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.7
7.4
40
155
E86
ICD-10 Finland
Volume depletion
4.1
7.4
20
50
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4.1
7.4
20
50
-51
ICPC
I&d/flush/aspiration
6.9
7.3
17
25
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.3
194
1327
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.9
7.3
101
575
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
7.3
40
156
BB1AN
NOMESCO Finland
Parathyroid gland isotope imaging, 1 isotope
+∞
7.3
7
*
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
+∞
7.3
7
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
+∞
7.3
7
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
7.3
7
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
+∞
7.3
7
*
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
7.3
7
*
C05AA08
ATC
fluocortolone; rectal, topical
1.9
7.2
100
570
XKC03
NOMESCO Finland
Water cystometry
3.2
7.2
28
90
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.4
7.2
25
75
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
30.3
7.2
9
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.8
7.2
34
123
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
20.2
7.1
10
5
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
4.1
7.1
19
47
S18
ICPC
Laceration/cut
1.5
7.1
314
2411
A10AB05
ATC
insulin aspart; parenteral
2.2
7.1
61
293
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.0
7.0
84
455
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.6
7.0
23
66
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.3
7.0
26
81
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
7.0
104
606
N91.1
ICD-10 Finland
Secondary amenorrhoea
6.4
7.0
17
27
M05BX04
ATC
denosumab; parenteral
2.5
7.0
42
172
E000003, ,
ATC
2.6
7.0
39
154
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
3.8
7.0
21
57
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
6.9
78
414
-64
ICPC
Encounter/prob initiated by provider
4.0
6.9
19
48
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
6.9
56
262
SPAT1284
SPAT
Extensive health certificate
3.6
6.9
22
62
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
6.9
54
249
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.5
6.9
23
67
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
3.3
6.9
25
77
D07AD01
ATC
clobetasol; topical
1.7
6.8
122
751
SPAT1139
SPAT
Nutrition survey
3.0
6.8
29
99
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.8
6.7
32
116
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.9
6.7
30
105
E66
ICD-10 Finland
Obesity
2.4
6.7
45
194
C08DB01
ATC
diltiazem; oral
2.7
6.7
34
128
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
6.6
211
1502
R11
ICD-10 Finland
Nausea and vomiting
2.1
6.6
67
342
U04
ICPC
Incontinence urine
2.5
6.6
40
164
W19
ICD-10 Finland
Unspecified fall
2.0
6.6
67
343
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
6.6
66
336
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.2
6.6
17
41
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
6.6
86
481
WZC15, ,
NOMESCO Finland
10.1
6.5
12
12
N03AX12
ATC
[U] gabapentin; oral
1.7
6.5
119
737
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
6.5
28
96
127
Kela drug reimbursment
Transplant complication
5.8
6.5
17
30
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.3
6.5
24
75
D06BX01
ATC
metronidazole; topical
1.9
6.4
84
469
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
70.4
6.4
7
*
JN4SR
NOMESCO Finland
Very extensive PET-CT of receptors in whole body
70.4
6.4
7
*
A10AE04
ATC
insulin glargine; parenteral
2.0
6.4
71
375
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
14.5
6.4
10
7
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.4
6.4
44
192
E66.00
ICD-10 Finland
Metabolic syndrome
2.4
6.4
44
192
K29.4
ICD-10 Finland
Chronic atrophic gastritis
4.1
6.4
17
42
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.4
6.4
43
186
SPAT1341
SPAT
Referral to physician or dentist
8.2
6.3
13
16
SPAT1110
SPAT
Measurement of pain intensity
8.2
6.3
13
16
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.0
6.3
27
92
N05AF03
ATC
chlorprothixene; systemic
3.3
6.3
23
71
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.1
6.3
56
272
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
6.3
135
872
B01AB05
ATC
enoxaparin; parenteral
1.5
6.3
213
1535
J01FA09
ATC
clarithromycin; systemic
1.5
6.3
228
1669
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
+∞
6.3
6
*
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
+∞
6.3
6
*
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
+∞
6.3
6
*
E23.2
ICD-10 Finland
Diabetes insipidus
+∞
6.3
6
*
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
+∞
6.3
6
*
E25.01
ICD-10 Finland
Congenital adrenal hyperplasia
+∞
6.3
6
*
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
+∞
6.3
6
*
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
+∞
6.3
6
*
E27.2
ICD-10 Finland
Addisonian crisis
+∞
6.3
6
*
A55
ICPC
General and Unspecified, Local injection/infiltration
7.1
6.2
14
20
JLC10
NOMESCO Finland
Distal pancreatectomy
26.9
6.2
8
*
A11CC02
ATC
dihydrotachysterol; oral
26.9
6.2
8
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
26.9
6.2
8
*
SPAT1131
SPAT
Colonoscopy
2.9
6.2
29
104
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
6.2
34
133
XJH00
NOMESCO Finland
Transanal ultrasonography
2.6
6.2
34
133
-1, ,
ICD-10 Finland
2.4
6.2
42
182
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
5.8
6.2
16
28
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
7.8
6.1
13
17
C09CA03
ATC
valsartan; oral
2.0
6.1
64
331
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
6.1
25
83
SPAT1353
SPAT
Intensive monitoring
12.6
6.1
10
8
G02CB03
ATC
cabergoline; oral
12.6
6.1
10
8
J01CA02
ATC
pivampicillin; oral
2.8
6.1
30
111
M05BA04
ATC
alendronic acid; oral
2.2
6.1
53
256
XX2VW
NOMESCO Finland
Radiologic consultation
10.1
6.0
11
11
N05BA01
ATC
diazepam; systemic, rectal
1.8
6.0
95
563
-69
ICPC
Other reason for encounter NEC
2.8
6.0
29
106

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
372
536
12.82
273.23
4.4
3.5
—
—
—
0
0
333
460
12.25
250.28
5.9
3.0
1.22
1.23
mmol/l
0.22
298
388
137
110
15.02
144.15
3.9
2.4
2.52
2.53
mmol/l
0.01
106
72
254
518
6.91
127.70
2.9
1.8
313.95
371.57
nmol/l
2.88
239
476
126
110
13.57
125.56
3.4
2.5
—
—
—
0
0
123
118
12.28
115.10
3.4
3.3
57.65
57.47
%
0.04
123
118
425
1657
4.62
94.90
4.2
3.7
0.00
0.01
estimate
0.17
296
569
435
1733
4.61
94.16
4.1
3.0
—
—
—
0
0
205
449
5.91
93.23
3.9
4.6
0.02
0.87
%
0.61
47
121
207
461
5.83
92.38
3.9
4.2
0.52
0.57
%
0.12
50
149
104
107
11.13
92.27
2.9
2.2
17.22
15.84
%
1.35
50
58
559
2734
5.13
90.74
20.3
8.8
0.00
0.00
e9/l
0.44
530
2269
207
477
5.62
88.66
3.9
4.5
0.10
0.15
%
0.39
50
149
210
506
5.38
85.21
3.8
4.4
0.64
1.03
%
1.00
53
179
89
82
12.18
84.91
3.6
2.3
—
—
—
0
0
135
219
7.30
82.58
3.3
1.3
337.84
305.01
mu/l
0.53
116
194
394
1675
3.86
72.94
6.3
3.4
7.40
7.40
ph
0.43
299
312
295
1131
3.66
61.90
3.0
2.6
477.60
537.27
mosm/kgh2o
4.65
268
970
462
2353
3.52
61.29
3.8
2.7
—
—
—
0
0
55
43
13.73
57.71
1.9
1.2
—
—
—
0
0
297
1202
3.44
56.33
2.4
1.7
28889368.12
11144420.65
pmol/l
0.26
225
1014
146
387
4.45
50.92
4.1
3.4
4.33
4.62
pmol/l
1.95
126
343
88
150
6.52
50.60
1.5
1.3
11.53
9.03
u/l
0.63
61
121
56
57
10.54
49.50
2.4
1.7
31.64
32.04
pg
0.19
56
57
281
1180
3.21
48.96
3.0
2.3
5.88
6.52
e6/l
0.25
256
1057
334
1649
2.85
42.23
4.0
3.5
—
—
—
0
0
437
2511
2.78
40.66
7.6
5.1
1.22
1.21
mmol/l
2.65
397
2285
52
64
8.66
39.76
2.5
1.9
—
—
—
0
0
47
54
9.22
37.89
2.0
1.2
—
—
nmol/l
—
0
0
492
3082
2.74
37.28
4.2
3.4
0.00
0.00
estimate
0.50
314
609
49
61
8.53
37.09
2.1
1.2
0.60
0.51
nmol/l
1.20
49
55
48
59
8.62
36.70
2.1
1.2
—
—
—
0
0
491
3092
2.71
36.47
4.7
4.6
0.00
0.00
estimate
0.50
313
583
428
2536
2.61
35.81
16.4
12.1
1.17
1.20
inr
0.75
346
754
381
2151
2.57
35.07
4.7
3.3
34.89
54.58
ng/l
0.49
281
1373
488
3124
2.62
34.03
4.2
3.4
0.00
0.01
estimate
0.50
303
563
353
1956
2.52
33.35
3.5
3.3
2.34
2.35
mmol/l
0.93
338
1735
299
1561
2.53
31.74
3.4
2.8
0.36
0.46
e6/l
0.45
260
1160
445
2783
2.48
31.73
8.1
5.9
1.22
1.21
mmol/l
0.40
181
2368
316
1704
2.48
31.15
3.4
2.9
128.01
111.32
e6/l
0.08
273
1287
204
892
2.77
31.01
4.2
3.0
0.82
0.82
mmol/l
0.17
191
847
168
670
2.94
30.28
6.3
5.1
1.00
1.05
mmol/l
1.74
159
626
291
1543
2.45
29.40
3.4
2.8
—
—
—
0
0
164
664
2.88
28.62
1.4
1.3
—
—
—
0
0
441
2860
2.32
27.35
10.5
6.3
—
—
—
0
0
52
96
5.75
27.31
3.2
2.5
—
—
—
0
0
631
4870
2.89
25.64
7.6
4.0
15.64
14.64
pmol/l
13.75
568
4435
393
2483
2.23
25.24
3.5
2.2
78.67
76.42
nmol/l
0.85
363
2239
169
738
2.67
25.23
2.8
2.2
22.58
22.88
%
0.10
144
630
98
323
3.34
24.19
1.7
1.3
21.58
26.62
iu/l
0.72
74
280
309
1825
2.18
22.90
3.4
2.5
60.63
102.86
u/l
0.47
267
1688
479
3384
2.16
21.88
6.3
4.3
6.76
6.61
mmol/l
0.73
457
3147
60
151
4.23
21.87
5.1
3.2
1.78
1.44
mg/l
1.60
53
138
447
3083
2.12
21.65
7.0
6.0
10.47
10.70
umol/l
0.09
419
2924
558
4204
2.29
21.42
5.3
3.6
—
—
—
0
0
280
1627
2.15
21.29
1.8
1.6
1.55
1.38
mmol/l
1.82
146
1389
179
865
2.41
21.23
2.8
2.2
12.86
13.31
umol/l
0.33
155
802
40
74
5.65
20.92
2.2
2.6
—
—
—
0
0
168
795
2.44
20.84
2.8
2.2
2.39
2.39
g/l
0.02
145
733
98
358
3.00
20.24
4.0
2.0
12.03
13.26
nmol/l
0.71
81
331
94
344
2.98
19.32
1.2
1.2
—
—
—
0
0
110
440
2.76
19.19
3.5
2.7
9.49
10.68
g/l
2.47
95
405
45
100
4.72
19.16
1.6
1.3
0.38
0.40
nmol/l
0.08
32
83
400
2735
1.99
18.81
7.5
5.9
0.67
0.69
%
0.21
386
2555
410
2832
1.99
18.68
7.3
5.9
2.64
2.81
%
0.86
395
2653
411
2848
1.98
18.47
7.5
6.1
8.44
8.40
%
0.10
397
2675
324
2071
2.00
18.37
3.8
3.3
114.77
105.74
e6/l
0.07
276
1400
587
4637
2.24
18.21
10.8
7.2
78.86
77.46
u/l
0.37
557
4347
366
2447
1.97
18.15
5.4
4.5
34.79
36.02
g/l
4.38
324
2283
659
5477
2.71
18.12
22.4
15.1
14.27
14.73
%
2.14
646
5388
244
1424
2.06
17.72
2.8
2.1
3.58
3.05
mg/l
2.41
216
1213
24
31
7.97
17.50
2.5
2.1
519.79
486.60
min
0.59
19
20
92
352
2.84
17.40
2.2
1.5
1.16
1.35
g/l
0.59
85
327
411
2935
1.89
15.98
7.5
5.9
26.98
28.45
%
2.24
398
2760
25
39
6.60
15.46
2.4
2.2
708.42
592.91
ml
0.50
19
23
563
4502
2.01
15.06
5.8
4.0
12.77
11.28
mm/h
1.72
518
4151
162
858
2.13
14.92
1.5
1.3
358.57
529.35
titre
0.68
28
184
177
976
2.07
14.62
2.9
1.7
1890.00
1211.38
nmol/l
13.34
128
722
154
806
2.15
14.59
1.4
1.2
—
—
—
0
0
237
1449
1.93
14.58
6.3
4.0
—
—
—
0
0
538
4276
1.92
14.11
4.9
4.1
—
—
—
0
0
410
3029
1.78
13.30
7.2
5.8
0.61
0.56
e9/l
3.67
388
2645
410
3033
1.78
13.20
7.2
5.8
0.04
0.04
e9/l
1.02
388
2651
94
416
2.44
13.18
4.4
2.7
77.27
72.06
e9/l
0.70
73
313
260
1684
1.83
13.10
2.7
2.0
143.18
191.43
u/l
1.54
227
1588
508
4008
1.83
13.10
5.3
4.1
3726.14
2505.20
e6/l
—
7
61
106
505
2.28
12.56
1.5
1.4
—
—
—
0
0
63
1423
0.39
12.02
3.8
3.4
—
—
—
0
0
140
763
2.03
11.73
1.2
1.2
—
—
—
0
0
390
2908
1.71
11.65
6.7
5.7
58.64
56.97
%
2.21
375
2735
414
3143
1.71
11.52
7.6
6.1
0.18
0.19
e9/l
0.44
392
2784
411
3127
1.70
11.23
7.3
5.8
1.83
1.93
e9/l
1.07
392
2800
345
2515
1.69
10.99
2.8
3.2
5.73
5.83
ph
0.17
13
217
371
2762
1.68
10.88
4.0
2.7
126.46
112.06
ug/l
0.57
322
2565
24
51
4.83
10.77
1.0
1.1
—
—
—
0
0
654
5745
2.10
10.44
8.2
4.7
1.61
1.86
mu/l
6.06
584
5290
102
515
2.14
10.42
2.0
2.2
0.20
0.22
g/l
1.60
93
488
262
1802
1.70
10.19
3.1
2.8
—
—
—
0
0
35
104
3.48
10.11
1.2
1.5
—
—
—
0
0
16
11
14.83
10.03
2.1
1.6
—
—
—
0
0
37
117
3.27
9.71
3.0
4.6
—
—
—
0
0
20
40
5.11
9.61
2.0
1.5
24.85
39.96
%
0.93
13
27
60
250
2.52
9.55
1.3
1.3
—
1.90
—
0
16
137
792
1.89
9.54
2.7
2.4
135.01
106.91
ug/g
0.58
94
631
66
1346
0.44
9.50
3.2
3.7
1.02
1.02
kg/l
—
7
176
219
1462
1.70
9.38
1.4
1.3
0.57
1.62
u/ml
2.70
100
417
51
199
2.68
9.26
1.7
1.8
1.72
2.49
ug/l
0.19
40
180
222
1495
1.69
9.17
2.4
2.5
341.02
6649.45
umol/l
5.80
192
1314
16
15
10.87
8.82
1.3
1.1
—
—
—
0
0
15
13
11.75
8.60
2.8
1.2
57.33
57.23
nmol/24h
0.00
15
13
234
1629
1.64
8.38
3.5
3.2
46.79
357.61
mg/l
2.23
136
1025
167
1064
1.73
8.36
3.8
2.8
2.46
2.44
mmol/l
1.53
160
932
220
1515
1.64
8.20
3.2
2.9
1113.99
1062.44
ng/l
0.09
167
1273
20
46
4.44
8.19
4.5
2.0
1.17
1.31
e9/l
0.29
20
40
691
6321
2.22
8.00
22.2
13.8
139.46
139.67
mmol/l
1.37
676
6142
19
29
6.69
7.92
1.2
1.3
—
—
—
0
0
29
92
3.24
7.61
1.4
1.3
62.10
63.37
mmol/l
0.05
21
83
691
6342
2.18
7.58
22.5
13.9
3.95
3.95
mmol/l
0.08
675
6149
43
171
2.61
7.55
1.3
1.4
276.12
302.74
ug/g
0.38
26
106
707
6558
2.42
7.40
23.1
11.8
—
—
—
0
0
239
1719
1.57
7.29
5.1
3.8
8.75
7.23
mg/mmol
0.31
140
1059
247
1793
1.56
7.23
3.5
3.0
7.30
7.64
mmol/l
0.51
185
1519
185
1255
1.63
7.20
1.7
1.4
2.40
2.37
g/l
0.06
130
784
429
3511
1.52
7.17
11.5
9.1
4.36
4.00
e9/l
2.48
409
3087
72
368
2.06
7.10
2.7
3.0
94.86
73.28
ng/l
0.50
35
326
171
1141
1.65
7.09
1.4
1.3
42.76
33.37
iu/ml
0.23
53
371
65
320
2.13
7.07
1.1
1.1
—
67.63
titre
—
0
8
80
428
1.97
6.96
1.9
3.0
67.87
67.10
g/l
0.47
73
391
101
585
1.84
6.91
3.0
2.7
1.86
1.77
%
0.45
87
519
17
28
6.19
6.80
2.0
4.5
—
—
—
0
0
627
5624
1.71
6.76
6.5
5.3
40.84
39.30
mmol/mol
3.06
559
5236
57
272
2.19
6.71
2.2
2.2
8106.96
3915.50
u/l
0.25
15
121
18
45
4.07
6.65
3.9
2.0
43.74
38.43
%
0.92
18
45
161
1076
1.63
6.60
1.4
1.3
7.87
11.88
u/ml
0.47
68
424
39
159
2.53
6.54
1.1
1.2
88.00
71.33
titre
—
5
15
75
402
1.96
6.49
1.3
1.2
244.99
226.91
u/ml
0.06
64
367
22
65
3.46
6.46
1.9
1.7
75.50
57.19
%
1.51
14
48
14
19
7.49
6.43
1.1
1.3
—
—
—
0
0
39
161
2.50
6.38
2.9
4.0
43.67
84.25
mg/l
—
6
137
39
161
2.50
6.38
2.9
4.0
34.47
30.02
mg/l
—
6
135
65
334
2.04
6.33
3.7
3.3
7.42
7.41
ph
0.31
44
45
112
688
1.74
6.28
1.8
1.5
—
—
—
0
0
68
359
1.98
6.15
2.1
2.6
—
—
—
0
0
14
21
6.77
6.05
2.1
1.4
3.00
7.29
%
—
6
7
17
45
3.84
5.84
1.2
1.1
—
—
—
0
0
56
1030
0.51
5.77
3.1
3.6
42.00
254.57
ng/l
4.46
35
750
34
142
2.46
5.45
3.6
2.2
81.14
78.72
ug/min
0.02
23
89
670
6222
1.74
5.10
20.1
12.5
18.66
22.48
mg/l
2.30
603
4857
19
60
3.22
5.07
2.9
6.1
7.59
7.00
mmol/l
0.29
19
53
27
106
2.61
4.93
1.7
1.7
—
—
—
0
0
185
1358
1.48
4.86
1.7
1.7
1.02
1.03
mg/l
0.03
126
1036
15
42
3.62
4.78
1.1
1.7
0.73
2.00
u/field
0.83
15
31
483
4227
1.40
4.59
4.0
2.9
59.40
44.72
u/l
1.77
427
3962
257
2027
1.41
4.54
3.0
3.1
31.11
32.18
u/l
0.25
228
1929
17
55
3.14
4.38
1.2
1.3
—
—
—
0
0
19
466
0.39
4.21
3.6
3.3
—
—
—
0
0
12
25
4.86
4.20
1.1
1.3
148.50
163.23
mmol/24h
0.27
12
25
26
110
2.41
4.11
1.2
1.3
—
—
—
0
0
10
19
5.32
3.83
1.2
1.1
—
—
—
0
0
15
49
3.10
3.82
1.0
1.0
—
—
—
0
0
15
381
0.38
3.62
2.3
2.4
—
—
—
0
0
7
9
7.84
3.56
2.0
1.0
—
—
—
0
0
15
52
2.92
3.48
1.3
1.2
—
—
—
0
0
20
439
0.44
3.41
1.5
1.4
—
—
—
0
0
300
2514
1.32
3.38
2.1
2.0
—
—
—
0
0
113
808
1.47
3.33
2.6
2.0
—
—
—
0
0
103
730
1.48
3.18
1.6
1.7
—
—
—
0
0
18
73
2.50
3.15
3.1
3.0
—
—
—
0
0
42
239
1.80
3.12
1.4
1.2
—
—
—
0
0
43
714
0.58
3.11
1.1
1.4
—
—
—
0
0
23
107
2.19
2.99
1.0
1.1
—
—
—
0
0
15
57
2.66
2.98
1.5
1.3
—
—
—
0
0
58
880
0.63
2.91
4.2
2.7
9.65
3.25
e6/l
0.86
33
447
27
494
0.53
2.75
16.6
3.4
5.80
5.81
kpa
0.03
27
478
168
1332
1.34
2.70
1.6
1.5
21.30
20.96
nmol/l
0.08
131
1146
27
487
0.54
2.64
16.7
3.4
1.61
2.17
mmol/l
0.41
21
400
24
121
2.02
2.58
1.3
1.4
—
—
—
0
0
5
163
0.30
2.58
1.6
3.0
—
—
—
0
0
98
718
1.42
2.56
2.0
1.3
—
—
—
0
0
5
7
7.18
2.55
1.4
1.0
—
—
—
0
0
5
161
0.31
2.43
1.8
2.0
36.90
37.93
g/l
—
5
148
22
411
0.52
2.42
17.2
2.9
4.68
4.60
kpa
0.07
22
395
11
38
2.92
2.42
4.7
7.3
—
—
—
0
0
15
316
0.46
2.36
22.5
3.5
128.67
128.62
g/l
0.00
15
311
689
6637
1.48
2.24
14.6
9.8
27.66
26.12
u/l
1.38
656
6412
24
128
1.90
2.23
1.3
1.3
10.89
110.00
e6/l
1.28
18
104
24
128
1.90
2.23
1.1
1.2
4.09
3.68
mmol/l
0.68
19
118
24
128
1.90
2.23
1.3
1.2
16.20
6.12
e6/l
0.34
15
101
11
41
2.71
2.21
1.4
1.5
86.27
75.49
umol/l
0.51
11
41
97
736
1.37
2.08
1.8
1.6
—
—
—
0
0
7
176
0.39
2.05
2.1
1.5
—
—
—
0
0
67
478
1.44
2.05
1.3
1.2
108.00
142.10
iu/ml
0.35
23
202
21
111
1.92
2.02
1.4
1.4
91.00
107.81
u/ml
—
6
26
33
202
1.66
1.98
1.2
1.3
—
—
—
0
0
163
1343
1.27
1.95
4.9
4.6
1.70
2.30
ug/l
1.38
137
1208
5
11
4.57
1.94
3.8
1.4
—
—
—
0
0
6
16
3.77
1.94
4.3
1.1
284.17
114.09
nmol/l
—
6
11
7
170
0.41
1.93
1.9
1.4
—
—
—
0
0
7
170
0.41
1.93
1.9
1.4
—
—
—
0
0
46
667
0.67
1.90
14.2
6.6
104.93
104.08
mmol/l
0.78
46
667
31
489
0.62
1.89
1.3
1.2
—
—
—
0
0
13
264
0.48
1.89
7.3
9.8
—
—
—
0
0
9
200
0.44
1.85
1.7
1.2
—
—
—
0
0
28
448
0.61
1.82
1.7
2.3
6.85
6.36
ug/l
0.08
22
400
628
5999
1.29
1.82
5.3
4.3
5.95
5.86
mmol/l
0.92
539
5486
157
1873
0.80
1.79
2.4
2.2
—
—
—
0
0
11
47
2.36
1.78
1.0
1.1
—
—
—
0
0
26
419
0.61
1.75
13.7
7.7
—
—
—
0
0
8
30
2.68
1.72
2.9
4.2
—
—
—
0
0
12
242
0.49
1.72
27.5
2.9
0.70
0.65
%
0.16
12
242
16
82
1.97
1.70
2.8
3.0
1.38
0.89
%
0.38
16
74
716
6992
1.56
1.70
29.9
18.6
40.55
40.30
%
0.68
690
6592
29
180
1.64
1.69
2.0
1.8
2.41
5.39
iu/l
2.50
13
67
716
6997
1.54
1.63
29.7
18.6
261.11
254.40
e9/l
1.51
701
6825
129
1057
1.27
1.62
1.7
1.6
—
—
—
0
0
716
6999
1.54
1.60
29.5
18.5
30.11
30.22
pg
0.75
703
6897
716
6999
1.54
1.60
29.5
18.5
90.99
90.72
fl
0.76
703
6899
716
7000
1.53
1.59
29.5
18.6
6.97
6.64
e9/l
3.90
701
6806
716
7000
1.53
1.59
29.6
18.6
4.49
4.50
e12/l
0.24
701
6812
28
432
0.63
1.58
1.4
1.4
—
—
—
0
0
37
537
0.67
1.57
4.9
2.5
27.42
41.39
u/l
0.94
31
456
35
513
0.67
1.56
5.6
3.7
—
—
—
0
0
716
7004
1.52
1.53
30.1
18.7
134.35
135.39
g/l
1.03
703
6901
28
179
1.59
1.47
3.0
2.3
—
—
—
0
0
14
253
0.54
1.46
2.9
3.4
24.14
25.20
mmol/l
0.51
14
246
14
253
0.54
1.46
29.6
3.3
24.28
24.36
mmol/l
0.04
14
246
9
40
2.26
1.40
1.3
1.5
—
—
—
0
0
18
104
1.75
1.38
1.1
1.1
11.30
61.49
iu/ml
—
10
29
54
715
0.74
1.37
1.6
1.4
—
—
—
0
0
72
561
1.31
1.35
3.8
4.4
6.32
28.41
ug/l
0.90
55
464
25
160
1.58
1.33
2.3
2.0
4.58
11.43
mg/l
5.42
20
147
14
244
0.57
1.31
5.1
3.3
—
—
—
0
0
17
280
0.60
1.29
1.8
3.2
—
—
—
0
0
615
5921
1.22
1.27
4.3
3.7
1.41
1.27
mmol/l
3.67
528
5461
18
107
1.70
1.26
1.1
1.3
—
—
—
0
0
28
187
1.52
1.25
2.5
2.6
—
—
—
0
0
149
1279
1.21
1.23
2.1
1.9
—
—
—
0
0
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
19
117
1.64
1.19
1.5
1.2
286.92
244.54
u/ml
0.27
12
71
7
30
2.35
1.12
6.0
2.8
416.14
949.20
u/ml
—
7
30
15
88
1.72
1.12
2.1
1.6
—
—
—
0
0
10
51
1.97
1.11
1.3
1.4
—
—
—
0
0
31
218
1.44
1.11
1.8
2.1
1.47
1.47
g/l
0.01
24
194
76
615
1.26
1.10
1.4
1.4
—
—
—
0
0
7
32
2.20
1.08
1.0
1.0
—
—
—
0
0
8
147
0.54
1.04
1.6
2.4
—
—
—
0
0
7
35
2.01
1.00
1.0
1.0
—
—
—
0
0
7
35
2.01
1.00
2.3
1.5
—
—
—
0
0
18
116
1.57
0.97
1.6
1.7
—
—
—
0
0
14
85
1.66
0.95
1.2
1.3
—
25.30
—
0
6
11
62
1.79
0.94
1.0
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.3
113.17
149.67
nmol/l
—
6
27
5
104
0.48
0.89
63.6
3.6
—
—
—
0
0
98
840
1.19
0.85
1.9
1.9
30.94
29.51
s
2.05
92
815
58
471
1.25
0.85
1.5
1.5
—
—
—
0
0
12
73
1.65
0.82
1.1
1.1
1.38
1.44
g/l
0.22
12
66
25
181
1.39
0.81
1.4
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
48
386
1.26
0.78
1.5
1.3
53.34
31.92
au/ml
—
5
24
632
6165
1.16
0.77
5.0
4.2
4.63
4.75
mmol/l
2.16
544
5739
47
580
0.80
0.77
6.1
7.3
1.95
1.18
mmol/l
0.67
34
465
11
67
1.65
0.75
3.5
4.8
91.78
108.98
u/ml
—
5
23
5
25
2.01
0.72
1.2
1.8
—
—
—
0
0
7
40
1.76
0.71
1.1
1.5
163.29
171.84
pmol/l
—
7
40
28
212
1.33
0.71
3.5
4.0
—
—
—
0
0
28
212
1.33
0.71
2.3
1.8
—
—
—
0
0
5
26
1.93
0.70
1.6
1.1
—
—
—
0
0
629
6144
1.15
0.70
4.9
4.1
1.43
1.49
mmol/l
2.97
540
5694
9
58
1.56
0.70
1.1
1.4
33.11
33.43
g/l
—
9
53
5
91
0.55
0.67
1.4
1.4
13.56
26.33
u/l
—
5
76
22
162
1.37
0.67
1.2
1.1
—
—
—
0
0
85
739
1.17
0.66
2.0
1.7
—
—
—
0
0
17
121
1.41
0.62
2.2
2.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.8
—
1276.00
—
0
12
0
21
0.00
0.60
0.0
3.7
—
—
—
0
0
8
53
1.51
0.58
1.1
1.7
—
—
—
0
0
7
114
0.61
0.58
1.1
1.1
—
11.45
—
0
10
75
655
1.16
0.56
2.6
2.5
5.39
7.72
umol/l
1.41
44
565
10
148
0.67
0.55
1.5
4.3
—
—
—
0
0
8
122
0.65
0.55
2.5
3.6
39.20
26.02
mg/l
—
8
76
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
135
1476
0.90
0.54
4.3
3.5
94.91
93.27
%
0.31
129
1435
27
214
1.27
0.53
1.3
1.6
—
—
—
0
0
9
63
1.43
0.52
1.1
1.1
—
—
—
0
0
6
99
0.60
0.52
1.2
1.2
—
—
—
0
0
14
100
1.41
0.52
1.0
1.1
—
—
—
0
0
14
191
0.73
0.51
1.2
1.2
—
—
—
0
0
11
75
1.47
0.51
1.4
1.1
—
—
—
0
0
9
65
1.39
0.50
1.2
1.3
—
—
—
0
0
40
337
1.20
0.47
2.5
4.2
—
—
—
0
0
30
249
1.21
0.42
2.2
1.7
—
—
—
0
0
26
213
1.23
0.41
2.0
1.8
22.42
20.93
s
0.40
19
192
14
105
1.34
0.41
1.3
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
1.87
—
0
15
637
6275
1.10
0.40
5.2
4.6
2.75
2.82
mmol/l
1.23
545
5802
166
1768
0.92
0.40
1.9
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
11.24
—
0
11
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
10
72
1.39
0.37
1.5
1.2
—
—
—
0
0
144
1533
0.92
0.35
5.4
6.7
—
—
—
0
0
18
221
0.81
0.34
1.3
1.3
284.83
241.65
miu/ml
—
7
110
33
285
1.17
0.32
2.2
2.4
0.42
0.20
e6/l
0.34
33
275
24
202
1.19
0.31
1.5
3.1
24.92
1063.62
u/ml
0.86
17
172
8
63
1.27
0.28
11.1
6.3
13.26
11.41
mg/l
—
8
58
293
2842
1.05
0.26
2.5
2.5
—
—
—
0
0
5
75
0.66
0.26
1.4
1.3
—
—
—
0
0
9
72
1.25
0.25
2.6
2.6
—
—
—
0
0
35
392
0.89
0.25
1.7
1.7
—
—
—
0
0
25
285
0.87
0.23
1.1
1.1
—
—
—
0
0
221
2283
0.95
0.22
1.7
1.9
97.52
96.58
pmol/l
0.09
109
1167
5
42
1.19
0.21
1.4
1.5
0.81
1.00
g/l
—
5
42
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
6.1
—
—
—
0
0
0
12
0.00
0.21
0.0
5.3
—
—
—
0
0
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
1.17
—
0
12
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
10
122
0.82
0.19
1.8
1.1
—
—
—
0
0
30
270
1.12
0.19
2.2
1.7
—
—
—
0
0
30
271
1.11
0.18
2.2
1.7
—
—
—
0
0
30
271
1.11
0.18
2.2
1.7
—
—
—
0
0
75
788
0.95
0.15
3.9
2.8
0.73
0.72
ug/l
0.09
56
481
26
284
0.91
0.13
2.2
2.3
—
—
—
0
0
29
269
1.08
0.11
2.1
1.7
—
—
—
0
0
45
428
1.05
0.09
2.3
2.7
3.73
7.16
e9/l
1.44
39
356
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
5
62
0.81
0.08
1.6
1.3
—
—
—
0
0
11
122
0.90
0.07
1.7
1.1
—
—
—
0
0
17
158
1.08
0.06
1.4
1.2
—
—
—
0
0
43
419
1.03
0.03
1.1
1.2
—
—
—
0
0
13
137
0.95
0.01
1.2
1.2
—
—
—
0
0
27
267
1.01
0.00
1.1
1.1
—
—
—
0
0
26
258
1.01
0.00
1.3
1.7
—
—
—
0
0
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
9
94
0.96
-0.00
1.1
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.7
—
—
—
0
0
5
53
0.94
-0.00
1.2
2.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
37.80
—
0
5
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.1
—
0.11
—
0
20
0
5
0.00
-0.00
0.0
1.0
—
73.46
—
0
5
5
50
1.00
-0.00
1.0
1.1
—
1.20
nmol/l
—
0
6
0
7
0.00
-0.00
0.0
7.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ENDODISNAS and mortality.

Females

Parameter HR [95% CI] p-value
E4_ENDODISNAS 1.723 [1.5, 1.98] < 0.001
Birth year 0.997 [0.99, 1.01] 0.433

During the follow-up period (1.1.1998 — 31.12.2019), 435 out of 2137 females with E4_ENDODISNAS died.

Males

Parameter HR [95% CI] p-value
E4_ENDODISNAS 2.082 [1.77, 2.45] < 0.001
Birth year 0.992 [0.98, 1.0] 0.076

During the follow-up period (1.1.1998 — 31.12.2019), 361 out of 1294 males with E4_ENDODISNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_ENDODISNAS.

N-year risk Females Males
1 0.181% 0.487%
5 0.917% 2.933%
10 2.625% 6.936%
15 5.304% 12.736%
20 8.779% 21.356%

Relationships between endpoints

↥

Index endpoint: E4_ENDODISNAS – Endocrine disorders, other/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data